Callio raises $187m for proof-of-concept for dual-payload ADC
Frazier Life Sciences led the financing round with contributions from other investors.
Syngene Thematic ADC WP
FDA grants fast track status to Pyxis’ PYX-201
Pfizer sets sights on Summit’s bispecific in combo with its ADCs
Hiroyuki Okuzawa succeeds Sunao Manabe as Daiichi Sankyo CEO
FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
BIA report: UK biotech investment surged to £3.5bn in 2024
FDA grants ODD status to Zai Lab’s lung cancer treatment
Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m
